Clearance prediction for Amgen molecules against Extended Clearance Classification System (ECCS) and future directions
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference31 articles.
1. Deloitte UK ten years on measuring return on pharma innovation report 2019;Deloitte L.L.P,2019
2. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings;Lipinski;Adv Drug Deliv Rev,1997
3. A ‘Rule of Three’ for fragment-based lead discovery?;Congreve;Drug Discov Today,2003
4. Beyond the Rule of 5: lessons learned from AbbVie's drugs and compound collection;DeGoey;J Med Chem,2018
5. Physiochemical drug properties associated with in vivo toxicological outcomes;Hughes;Bioorg Med Chem,2008
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CNS delivery of targeted protein degraders;Journal of Controlled Release;2024-08
2. Drug Design and Success of Prospective Mouse In Vitro–In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CLp) from Hepatocyte Intrinsic Clearance (CLint);Molecular Pharmaceutics;2023-05-26
3. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes;The AAPS Journal;2023-04-13
4. Plasma protein-mediated uptake and contradictions to the free drug hypothesis: a critical review;Drug Metabolism Reviews;2023-04-12
5. Trends in small molecule drug properties: A developability molecule assessment perspective;Drug Discovery Today;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3